Post by Curia

This week’s API Spotlight: Pralidoxime Chloride, a small‑molecule antidote used as an adjunct therapy in the treatment of organophosphate poisoning and other acetylcholinesterase inhibitor exposures. Produced at our Rensselaer, New York site, Pralidoxime Chloride is supported by a team of experts dedicated to cGMP small‑molecule API manufacturing. Their technical expertise helps ensure reliable, high‑quality production to meet critical medical and regulatory needs. To support your development and regulatory strategy, a US DMF is already available for this molecule. Learn more about our API capabilities here: https://hubs.li/Q04dKC_M0 #SmallMolecules #APIManufacturing #GenericAPIs #Curia